Human Hypertension and P450 Co-Hydroxylases and Epoxygenases

人类高血压与 P450 辅羟化酶和环氧合酶

基本信息

  • 批准号:
    7758891
  • 负责人:
  • 金额:
    $ 35.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-05 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

The kidney plays a key role in the control of body fluid volume and composition, and tubular and/or hemodynamic dysfunction are common features of diseases such as hypertension and diabetes. The renal P450 arachidonic acid (AA) monooxygenase biosynthesizes hydroxy- and epoxy-AA derivatives that are known to modulate tubular transport and vascular reactivity. Animal models of P450 gene dysfunction confirmed the physiological importance of these enzymes, characterized their pathophysiological roles, and provided insights into the mechanism of action of their metabolites. Studies of the pathophysiological roles of human P450s identified associations between P450 gene variants with hypertension, the progression of renal disease, and with components of metabolic syndrome. This application proposes to build upon these studies and to address: a) mechanisms by which the P450-eicosanoids regulate renal tubular transport and vascular reactivity, b) the role of P450s in human hypertension and renal complications of diabetes, and c) the molecular basis of these pathophysiological roles. To achieve these goals, we developed a multidisciplinary approach for studies of P450-isoform specific phenotypes at the cellular, organ and whole animal levels, the analysis of associations between alterations in human P450 gene structure/expression and disease, and for clinical studies of their metabolic and functional consequences. Cyp2c and Cyp4a knockout mice will be used to study gene-dependent changes in: a) renal EET and/or 20-HETE synthase expression, b) tubular transport and/or vascular reactivity, and c) systemic blood pressure and the progression of renal disease. Associations between CYP2C8/2C9 or CYP4A11 genotypes with blood pressure, insulin sensitivity, and urine and plasma EET and 20-HETE levels will be explored to define pathophysiological correlations between variant alleles, AA epoxidation/hydroxylation, and individual responses to changes in dietary salt intake, the administration of diuretics, or peroxisomal proliferator activated receptor (alpha) ligands. Our long term goals are to provide a molecular understanding of role(s) of P450 eicosanoids in renal physiological, their mechanism and site of action, and relevance to human disease. These are needed for the development of meaningful approaches for: a) the unequivocal definition of human pathophysiological significance, and b) future pharmacological targeting, and clinical diagnosis and intervention.
肾脏在控制体液容量和成分以及肾小管和/或 血流动力学障碍是高血压和糖尿病等疾病的常见特征。肾脏 P450花生四烯酸(AA)单加氧酶生物合成羟基和环氧AA衍生物,这些衍生物 已知可调节肾小管运输和血管反应性。P450基因功能障碍的动物模型 确认了这些酶的生理重要性,表征了它们的病理生理作用,以及 提供了对其代谢物的作用机制的见解。血管紧张素转换酶的病理生理作用研究 人类P450发现P450基因变异与高血压、高血压进展 肾脏疾病,并与代谢综合征的组成部分。此应用程序建议在这些基础上构建 研究和解决:a)P450-二十烷类化合物调节肾小管运输和 血管反应性,b)P450在人类高血压和糖尿病肾脏并发症中的作用,以及c) 这些病理生理作用的分子基础。为了实现这些目标,我们开发了一个多学科的 细胞、器官和整个动物中P450亚型特异性表型的研究方法 水平,分析人类P450基因结构/表达变化与 以及对其代谢和功能后果的临床研究。Cyp2c和Cyp4a基因敲除 小鼠将被用来研究基因依赖性的变化:a)肾脏EET和/或20-HETE合成酶的表达, B)肾小管运输和/或血管反应性,以及c)全身血压和肾脏进展 疾病。CYP2C8/2C9或CYP4A11基因与血压、胰岛素敏感性、 尿液和血浆中的EET和20-HETE水平将被用来确定病理生理相关性。 变异等位基因、AA环氧化/羟化和个体对饮食盐变化的反应之间的关系 服用利尿剂或过氧化体增殖物激活受体(α)配体。我们的 长期目标是提供对P450二十烷类化合物在肾脏中作用的分子理解(S) 生理学,它们的机制和作用部位,以及与人类疾病的相关性。这些都是需要的 发展有意义的方法:a)明确定义人类病理生理学 意义,以及b)未来的药理靶向,以及临床诊断和干预。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nancy Brown其他文献

Nancy Brown的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nancy Brown', 18)}}的其他基金

Human Hypertension and P450 Co-Hydroxylases and Epoxygenases
人类高血压与 P450 辅羟化酶和环氧合酶
  • 批准号:
    8326677
  • 财政年份:
  • 资助金额:
    $ 35.03万
  • 项目类别:
Human Hypertension and P450 Co-Hydroxylases and Epoxygenases
人类高血压与 P450 辅羟化酶和环氧合酶
  • 批准号:
    8521251
  • 财政年份:
  • 资助金额:
    $ 35.03万
  • 项目类别:
Human Hypertension and P450 Co-Hydroxylases and Epoxygenases
人类高血压与 P450 辅羟化酶和环氧合酶
  • 批准号:
    8111792
  • 财政年份:
  • 资助金额:
    $ 35.03万
  • 项目类别:
Human Hypertension and P450 Co-Hydroxylases and Epoxygenases
人类高血压与 P450 辅羟化酶和环氧合酶
  • 批准号:
    8379574
  • 财政年份:
  • 资助金额:
    $ 35.03万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.03万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了